Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole.

NCT00623519 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00623519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00623519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 30, 2004
Completion date
February 28, 2009
Enrollment
165 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer